Julian - Interview 33  

Julian - Interview 33

Age at Interview: 61
Sex: Male
Background: Julian is a research scientist and author, married, with 3 adult children. Ethnic background/nationality: White English Jewish.

Brief outline:Julian has prostate cancer. He is in a Phase 1 trial of a drug (a PARP inhibitor) which may stop cancer cells regrowing in people like him who have the BRCA2 genetic mutation. This mutation increases the risk of prostate and other cancers.

More about me...

To watch or read an interview clip, click on the heading that interests you. Either a video,audio recording or text will open, depending on the clip
To close transcript boxes, click here
To print the interview’s text, click here
Male
It’s difficult to advise others, but Julian recommends taking part in a trial, both because it helps others and because you get close monitoring and attention.

 



For patients who are thinking of enrolling in trials, I’d - I don’t know, it’s so difficult to give advice to other people. I think it’s a good thing to do. I’d encourage it, and there are several reasons. So there’s an altruistic reason - by enrolling in the trial you may help other people, so that’s a very important thing. And there’s a selfish reason as well, and that is if you enrol in a trial you’ll get much closer attention from medical staff than you would otherwise get. And they’ll probably be rather good medical staff as well because they’re active in research and intelligent people who really care about what’s going on with their particular batch of patients. So for both those reasons I’d say, “Yeah, enrol in a trial if you’ve got a chance.” 

Clinical trials
   Support our work

Mail to a friend

Send